Healthy Returns: J&J cell therapy gains new edge over Bristol Myers rival
April 9, 2024 Comments Off
J&J’s cell therapy is now approved for an earlier line of treatment than a competing drug from Bristol Myers. Meanwhile, a look at Mount Sinai’s approach to AI.
Healthy Returns: J&J cell therapy gains new edge over Bristol Myers rival
J&J’s cell therapy is now approved for an earlier line of treatment than a competing drug from Bristol Myers. Meanwhile, a look at Mount Sinai’s approach to AI.
Archives
Categories
Archives
Recent Posts
Meta
Categories
Calender